<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37215992</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1449-2288</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>8</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>International journal of biological sciences</Title><ISOAbbreviation>Int J Biol Sci</ISOAbbreviation></Journal><ArticleTitle>Dysregulated MicroRNAs in the Pathogenesis of Systemic Lupus Erythematosus: A Comprehensive Review.</ArticleTitle><Pagination><StartPage>2495</StartPage><EndPage>2514</EndPage><MedlinePgn>2495-2514</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7150/ijbs.74315</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus is a chronic autoimmune disease of which clinical presentation is vastly heterogeneous, ranging from mild skin rashes to severe renal diseases. Treatment goal of this illness is to minimize disease activity and prevent further organ damage. In recent years, much research has been done on the epigenetic aspects of SLE pathogenesis, for among the various factors known to contribute to the pathogenic process, epigenetic factors, especially microRNAs, bear the most therapeutic potential that can be altered unlike congenital genetic factors. This article reviews and updates what has been discovered so far about the pathogenesis of lupus, while focusing on the dysregulation of microRNAs in lupus patients in comparison to healthy controls along with the potentially pathogenic roles of the microRNAs commonly reported to be either upregulated or downregulated. Furthermore, this review includes microRNAs of which results are controversial, suggesting possible explanations for such discrepancies and directions for future research. Moreover, we aimed to emphasize the point that had been overlooked so far in studies regarding microRNA expression levels; that is, which specimen was used to assess the dysregulation of microRNAs. To our surprise, a vast number of studies have not considered this factor and have analyzed the potential role of microRNAs in general. Despite extensive investigations done on microRNA levels, their significance and potential role remain a mystery, which calls for further studies on this particular subject in regard of which specimen is used for assessment.</AbstractText><CopyrightInformation>&#xa9; The author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Daeun</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jimin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jae Won</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ji Hong</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Seoyeon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Jae Il</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Int J Biol Sci</MedlineTA><NlmUniqueID>101235568</NlmUniqueID><ISSNLinking>1449-2288</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">B lymphocyte</Keyword><Keyword MajorTopicYN="N">T lymphocyte</Keyword><Keyword MajorTopicYN="N">microRNA (miRNA)</Keyword><Keyword MajorTopicYN="N">plasmacytoid dendritic cell (pDC)</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus (SLE)</Keyword></KeywordList><CoiStatement>Competing Interests: The authors have declared that no competing interest exists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>19</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37215992</ArticleId><ArticleId IdType="pmc">PMC10197884</ArticleId><ArticleId IdType="doi">10.7150/ijbs.74315</ArticleId><ArticleId IdType="pii">ijbsv19p2495</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>D'Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet. 2007;369(9561):587&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">17307106</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairhurst AM, Wandstrat AE, Wakeland EK. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv Immunol. 2006;92:1&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">17145301</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56(7):481&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1769989</ArticleId><ArticleId IdType="pubmed">12835292</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter EE, Barr SG, Clarke AE. The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol. 2016;12(10):605&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">27558659</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev. 2009;23(7):781&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3959995</ArticleId><ArticleId IdType="pubmed">19339683</ArticleId></ArticleIdList></Reference><Reference><Citation>Javierre BM, Fernandez AF, Richter J, Al-Shahrour F, Martin-Subero JI, Rodriguez-Ubreva J. et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res. 2010;20(2):170&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2813473</ArticleId><ArticleId IdType="pubmed">20028698</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu A, La Cava A. Epigenetic dysregulation in systemic lupus erythematosus. Autoimmunity. 2014;47(4):215&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24128164</ArticleId></ArticleIdList></Reference><Reference><Citation>Foma AM, Aslani S, Karami J, Jamshidi A, Mahmoudi M. Epigenetic involvement in etiopathogenesis and implications in treatment of systemic lupus erythematous. Inflamm Res. 2017;66(12):1057&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">28741130</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X, Liu Q. MicroRNAs in the pathogenesis of systemic lupus erythematosus. Int J Rheum Dis. 2013;16(2):115&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">23773633</ArticleId></ArticleIdList></Reference><Reference><Citation>John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol. 2004;2(11):e363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC521178</ArticleId><ArticleId IdType="pubmed">15502875</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH. et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004;23(20):4051&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC524334</ArticleId><ArticleId IdType="pubmed">15372072</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J. et al. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003;425(6956):415&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">14508493</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003;17(24):3011&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC305252</ArticleId><ArticleId IdType="pubmed">14681208</ArticleId></ArticleIdList></Reference><Reference><Citation>Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K. et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature. 2005;436(7051):740&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2944926</ArticleId><ArticleId IdType="pubmed">15973356</ArticleId></ArticleIdList></Reference><Reference><Citation>Mah SM, Buske C, Humphries RK, Kuchenbauer F. miRNA*: a passenger stranded in RNA-induced silencing complex? Crit Rev Eukaryot Gene Expr. 2010;20(2):141&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21133843</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell. 2003;115(2):199&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">14567917</ArticleId></ArticleIdList></Reference><Reference><Citation>Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell. 2003;115(2):209&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">14567918</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley JB, Kelly JA, Kaufman KM. Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol. 2006;28(2):119&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">17021721</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko K, Franek BS, Marion M, Kaufman KM, Langefeld CD, Harley JB. et al. Genetic ancestry, serum interferon-alpha activity, and autoantibodies in systemic lupus erythematosus. J Rheumatol. 2012;39(6):1238&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3381952</ArticleId><ArticleId IdType="pubmed">22505704</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko K, Koldobskaya Y, Rosenzweig E, Niewold TB. Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients. Front Immunol. 2013;4:309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3787392</ArticleId><ArticleId IdType="pubmed">24101921</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S, Jin Z, Rosenzweig E, Rao S, Ko K, Niewold TB. Widely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populations. J Autoimmun. 2015;60:51&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457613</ArticleId><ArticleId IdType="pubmed">25921064</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez E, Comeau ME, Freedman BI, Kelly JA, Kaufman KM, Langefeld CD. et al. Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis Rheum. 2011;63(11):3493&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3205224</ArticleId><ArticleId IdType="pubmed">21792837</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC, Lo MS, Costa Reis P, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12(12):716&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">27872476</ArticleId></ArticleIdList></Reference><Reference><Citation>Dema B, Charles N. Autoantibodies in SLE: Specificities, Isotypes and Receptors. Antibodies (Basel) 2016. 5(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6698872</ArticleId><ArticleId IdType="pubmed">31557984</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzani E, Drosera M, Gasparini G, Parodi A. Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects. Autoimmune Dis. 2014;2014:321359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3932647</ArticleId><ArticleId IdType="pubmed">24649358</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med. 2000;124(1):71&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">10629135</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan A, Herrmann M, Munoz LE. Clearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLE. Front Immunol. 2016;7:35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4745266</ArticleId><ArticleId IdType="pubmed">26904025</ArticleId></ArticleIdList></Reference><Reference><Citation>Linker-Israeli M, Quismorio FP Jr, Horwitz DA. CD8+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis. Arthritis Rheum. 1990;33(8):1216&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">1975176</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2117903</ArticleId><ArticleId IdType="pubmed">17562483</ArticleId></ArticleIdList></Reference><Reference><Citation>Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature. 1997;390(6658):350&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">9389474</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan MJ. Apoptosis in systemic lupus erythematosus. Clin Immunol. 2004;112(3):210&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15308111</ArticleId></ArticleIdList></Reference><Reference><Citation>Papayannopoulos V, Zychlinsky A. NETs: a new strategy for using old weapons. Trends Immunol. 2009;30(11):513&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">19699684</ArticleId></ArticleIdList></Reference><Reference><Citation>Branzk N, Lubojemska A, Hardison SE, Wang Q, Gutierrez MG, Brown GD. et al. Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens. Nat Immunol. 2014;15(11):1017&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4236687</ArticleId><ArticleId IdType="pubmed">25217981</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrera C, Fadeel B. Macrophage clearance of neutrophil extracellular traps is a silent process. J Immunol. 2013;191(5):2647&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">23904163</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Sanchez C, Aguirre MA, Ruiz-Limon P, Barbarroja N, Jimenez-Gomez Y, de la Rosa IA. et al. 'Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients'. Sci Rep. 2016;6:31375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4977549</ArticleId><ArticleId IdType="pubmed">27502756</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L, Lu MP, Wang JH, Xu M, Yang SR. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2020;16(1):19&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7040062</ArticleId><ArticleId IdType="pubmed">30796732</ArticleId></ArticleIdList></Reference><Reference><Citation>Crispin JC, Kyttaris VC, Terhorst C, Tsokos GC. T cells as therapeutic targets in SLE. Nat Rev Rheumatol. 2010;6(6):317&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2924434</ArticleId><ArticleId IdType="pubmed">20458333</ArticleId></ArticleIdList></Reference><Reference><Citation>Saravia J, Chapman NM, Chi H. Helper T cell differentiation. Cell Mol Immunol. 2019;16(7):634&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6804569</ArticleId><ArticleId IdType="pubmed">30867582</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuyama T, Tsokos GC, Moulton VR. Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus. Front Immunol. 2018;9:1088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5967272</ArticleId><ArticleId IdType="pubmed">29868033</ArticleId></ArticleIdList></Reference><Reference><Citation>Simeoni L. Lck activation: puzzling the pieces together. Oncotarget. 2017;8(61):102761&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5732685</ArticleId><ArticleId IdType="pubmed">29262519</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC, Nambiar MP, Tenbrock K, Juang YT. Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE. Trends Immunol. 2003;24(5):259&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">12738420</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CP, Lin WJ, Huang M, Kappler JW, Marrack P. Development and function of T cells in T cell antigen receptor/CD3 zeta knockout mice reconstituted with Fc epsilon RI gamma. Proc Natl Acad Sci U S A. 1997;94(2):616&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC19562</ArticleId><ArticleId IdType="pubmed">9012833</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomou EE, Juang YT, Gourley MF, Kammer GM, Tsokos GC. Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J Immunol. 2001;166(6):4216&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">11238674</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Katakai T, Hara T, Gonda H, Sugai M, Shimizu A. Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation. J Cell Biol. 2004;167(2):327&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2172551</ArticleId><ArticleId IdType="pubmed">15504914</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Harada T, Juang YT, Kyttaris VC, Wang Y, Zidanic M. et al. Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus. J Immunol. 2007;178(3):1938&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">17237445</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H, Tan G, Guo Q, Pang R, Zeng F. Abnormal activation of the Akt-GSK3beta signaling pathway in peripheral blood T cells from patients with systemic lupus erythematosus. Cell Cycle. 2009;8(17):2789&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">19652548</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T, Qin X, Kurepa Z, Kumar KR, Liu K, Kanta H. et al. Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. J Clin Invest. 2007;117(8):2186&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1913486</ArticleId><ArticleId IdType="pubmed">17641780</ArticleId></ArticleIdList></Reference><Reference><Citation>Viallard JF, Pellegrin JL, Ranchin V, Schaeverbeke T, Dehais J, Longy-Boursier M. et al. Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE) Clin Exp Immunol. 1999;115(1):189&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1905189</ArticleId><ArticleId IdType="pubmed">9933441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleczynska W, Jakiela B, Plutecka H, Milewski M, Sanak M, Musial J. Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus. Folia Histochem Cytobiol. 2011;49(4):646&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">22252759</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu N, Xu M, Mizoguchi I, Furusawa J, Kaneko K, Watanabe K. et al. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases. Clin Dev Immunol. 2013;2013:968549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3728507</ArticleId><ArticleId IdType="pubmed">23956763</ArticleId></ArticleIdList></Reference><Reference><Citation>Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity. Cytokine. 2015;72(2):146&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">25647269</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolff S, Bijl M, Huitema MG, Limburg PC, Kallenberg CG, Abdulahad WH. Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus. Clin Immunol. 2011;141(2):197&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">21920821</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu MC, Lai NS, Chen HC, Yu HC, Huang KY, Tung CH. et al. Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis. Clin Exp Immunol. 2013;171(1):91&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530100</ArticleId><ArticleId IdType="pubmed">23199328</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu MC, Yu CL, Chen HC, Yu HC, Huang HB, Lai NS. Aberrant T cell expression of Ca2+ influx-regulated miRNAs in patients with systemic lupus erythematosus promotes lupus pathogenesis. Rheumatology (Oxford) 2015;54(2):343&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25172935</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan W, Liang D, Tang Y, Qu B, Cui H, Luo X. et al. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum. 2012;64(11):3715&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">22736314</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Zhang N, Zhang X, Qin M, Dong Y, Jin L. MiR-410 Down-Regulates the Expression of Interleukin-10 by Targeting STAT3 in the Pathogenesis of Systemic Lupus Erythematosus. Cell Physiol Biochem. 2016;39(1):303&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">27351906</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X. et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol. 2010;184(12):6773&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">20483747</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Li MY, Gao XF, Jia SJ, Gao KQ, Zhou Y. et al. Downregulation of BDH2 modulates iron homeostasis and promotes DNA demethylation in CD4(+) T cells of systemic lupus erythematosus. Clin Immunol. 2018;187:113&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">29113828</ArticleId></ArticleIdList></Reference><Reference><Citation>Suo QF, Sheng J, Qiang FY, Tang ZS, Yang YY. Association of long non-coding RNA GAS5 and miR-21 levels in CD4(+) T cells with clinical features of systemic lupus erythematosus. Exp Ther Med. 2018;15(1):345&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5769282</ArticleId><ArticleId IdType="pubmed">29387192</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin H, Zhu X, Liang J, Wu J, Yang Y, Wang S. et al. MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1. J Dermatol Sci. 2013;69(1):61&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">23142053</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, Wang Y, Liang Y, Zhao M, Long H, Ding S. et al. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum. 2011;63(5):1376&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">21538319</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W, Zhu S, Dai D, Liu Z, Li D, Li B. et al. MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis. Nat Commun. 2015;6:7096.</Citation><ArticleIdList><ArticleId IdType="pubmed">25963922</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding S, Liang Y, Zhao M, Liang G, Long H, Zhao S. et al. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum. 2012;64(9):2953&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">22549634</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L, Xu J. Role of MiR-98 and Its Underlying Mechanisms in Systemic Lupus Erythematosus. J Rheumatol. 2018;45(10):1397&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">29907673</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Ramos R, Garcia-Lozano JR, Lucena JM, Castillo-Palma MJ, Garcia-Hernandez F, Rodriguez MC. et al. Differential expression pattern of microRNAs in CD4+ and CD19+ cells from asymptomatic patients with systemic lupus erythematosus. Lupus. 2014;23(4):353&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24509687</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Wang Y, Qin H, Lin J, Xie L, Chen S. et al. Downregulation of miR-633 activated AKT/mTOR pathway by targeting AKT1 in lupus CD4(+) T cells. Lupus. 2019;28(4):510&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30760089</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Liu S, Luo S, Wu H, Tang M, Cheng W. et al. DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype. J Autoimmun. 2014;54:127&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">25091625</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu N, Li X, Song W, Li D, Yu D, Zeng X. et al. CD4(+)CD25 (+)CD127 (low/-) T cells: a more specific Treg population in human peripheral blood. Inflammation. 2012;35(6):1773&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">22752562</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun XG, Tao JH, Xiang N, Li XM, Wang GS, Fang X. et al. Negative Correlation Between miR-326 and Ets-1 in Regulatory T Cells from new-Onset SLE Patients. Inflammation. 2016;39(2):822&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26861134</ArticleId></ArticleIdList></Reference><Reference><Citation>Akkaya M, Kwak K, Pierce SK. B cell memory: building two walls of protection against pathogens. Nat Rev Immunol. 2020;20(4):229&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7223087</ArticleId><ArticleId IdType="pubmed">31836872</ArticleId></ArticleIdList></Reference><Reference><Citation>Marie-Cardine A, Divay F, Dutot I, Green A, Perdrix A, Boyer O. et al. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin Immunol. 2008;127(1):14&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">18191619</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood. 2005;105(11):4390&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1895038</ArticleId><ArticleId IdType="pubmed">15701725</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland SL, Leahy KF, Halverson R, Torres RM, Pelanda R. BAFF receptor signaling aids the differentiation of immature B cells into transitional B cells following tonic BCR signaling. J Immunol. 2010;185(8):4570&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2950883</ArticleId><ArticleId IdType="pubmed">20861359</ArticleId></ArticleIdList></Reference><Reference><Citation>Milne CD, Fleming HE, Zhang Y, Paige CJ. Mechanisms of selection mediated by interleukin-7, the preBCR, and hemokinin-1 during B-cell development. Immunol Rev. 2004;197:75&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">14962188</ArticleId></ArticleIdList></Reference><Reference><Citation>Erlandsson L, Licence S, Gaspal F, Lane P, Corcoran AE, Martensson IL. Both the pre-BCR and the IL-7Ralpha are essential for expansion at the pre-BII cell stage in vivo. Eur J Immunol. 2005;35(6):1969&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">15909309</ArticleId></ArticleIdList></Reference><Reference><Citation>Milne CD, Paige CJ. IL-7: a key regulator of B lymphopoiesis. Semin Immunol. 2006;18(1):20&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">16303314</ArticleId></ArticleIdList></Reference><Reference><Citation>Pers JO, Daridon C, Devauchelle V, Jousse S, Saraux A, Jamin C. et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci. 2005;1050:34&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16014518</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson A. The rationale for BAFF inhibition in systemic lupus erythematosus. Curr Rheumatol Rep. 2012;14(4):295&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3389191</ArticleId><ArticleId IdType="pubmed">22535567</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Santini PA, Matthews AJ, Chiu A, Plebani A, He B. et al. Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF. J Immunol. 2008;181(1):276&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3048768</ArticleId><ArticleId IdType="pubmed">18566393</ArticleId></ArticleIdList></Reference><Reference><Citation>He B, Qiao X, Cerutti A. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol. 2004;173(7):4479&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">15383579</ArticleId></ArticleIdList></Reference><Reference><Citation>Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F. et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity. 2004;20(6):785&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">15189742</ArticleId></ArticleIdList></Reference><Reference><Citation>Ota M, Duong BH, Torkamani A, Doyle CM, Gavin AL, Ota T. et al. Regulation of the B cell receptor repertoire and self-reactivity by BAFF. J Immunol. 2010;185(7):4128&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3263398</ArticleId><ArticleId IdType="pubmed">20817867</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson A. Targeting BAFF in autoimmunity. Curr Opin Immunol. 2010;22(6):732&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2997938</ArticleId><ArticleId IdType="pubmed">20970975</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin L, Waseem TC, Sahoo A, Bieerkehazhi S, Zhou H, Galkina EV. et al. Insights Into the Molecular Mechanisms of T Follicular Helper-Mediated Immunity and Pathology. Front Immunol. 2018;9:1884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6104131</ArticleId><ArticleId IdType="pubmed">30158933</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitano M, Moriyama S, Ando Y, Hikida M, Mori Y, Kurosaki T. et al. Bcl6 protein expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity. Immunity. 2011;34(6):961&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">21636294</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JY, Ho JH, Pasoto SG, Bunin V, Kim ST, Carrasco S. et al. Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol. 2015;67(4):988&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4450082</ArticleId><ArticleId IdType="pubmed">25581113</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Tsai LM, Leong YA, Hu X, Ma CS, Chevalier N. et al. Circulating precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity. 2013;39(4):770&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">24138884</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR. et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity. 2010;32(1):129&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">20079667</ArticleId></ArticleIdList></Reference><Reference><Citation>Oleinika K, Mauri C, Salama AD. Effector and regulatory B cells in immune-mediated kidney disease. Nat Rev Nephrol. 2019;15(1):11&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">30443016</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan MM, Thompson-Snipes L, Klintmalm G, Demetris AJ, O'Leary J, Oh S. et al. CD24(hi)CD38(hi) and CD24(hi)CD27(+) Human Regulatory B Cells Display Common and Distinct Functional Characteristics. J Immunol. 2019;203(8):2110&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">31511354</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Borja F, Bosma A, Ng D, Reddy V, Ehrenstein MR, Isenberg DA. et al. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med. 2013;5(173):173ra23.</Citation><ArticleIdList><ArticleId IdType="pubmed">23427243</ArticleId></ArticleIdList></Reference><Reference><Citation>Taher TE, Ong VH, Bystrom J, Hillion S, Simon Q, Denton CP. et al. Association of Defective Regulation of Autoreactive Interleukin-6-Producing Transitional B Lymphocytes With Disease in Patients With Systemic Sclerosis. Arthritis Rheumatol. 2018;70(3):450&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">29193892</ArticleId></ArticleIdList></Reference><Reference><Citation>Piper CJM, Wilkinson MGL, Deakin CT, Otto GW, Dowle S, Duurland CL. et al. CD19(+)CD24(hi)CD38(hi) B Cells Are Expanded in Juvenile Dermatomyositis and Exhibit a Pro-Inflammatory Phenotype After Activation Through Toll-Like Receptor 7 and Interferon-alpha. Front Immunol. 2018;9:1372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6024011</ArticleId><ArticleId IdType="pubmed">29988398</ArticleId></ArticleIdList></Reference><Reference><Citation>Burton H, Dorling A. Transitional B cell subsets-a convincing predictive biomarker for allograft loss? Kidney Int. 2017;91(1):18&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">28003081</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Guo Q, Wu C, Sterlin D, Goswami S, Zhang Y. et al. Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients. Cell Mol Immunol. 2019;16(4):367&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6461980</ArticleId><ArticleId IdType="pubmed">29563616</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon Q, Pers JO, Cornec D, Le Pottier L, Mageed RA, Hillion S. In-depth characterization of CD24(high)CD38(high) transitional human B cells reveals different regulatory profiles. J Allergy Clin Immunol. 2016;137(5):1577&#x2013;84. e10.</Citation><ArticleIdList><ArticleId IdType="pubmed">26525227</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvajal Alegria G, Gazeau P, Hillion S, Daien CI, Cornec DYK. Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases? Clin Rev Allergy Immunol. 2017;53(2):219&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">28474288</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zhao P, Ma L, Shan Y, Jiang Z, Wang J. et al. Increased interleukin 21 and follicular helper T-like cells and reduced interleukin 10+ B cells in patients with new-onset systemic lupus erythematosus. J Rheumatol. 2014;41(9):1781&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">25028374</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu XN, Ye YX, Niu JW, Li Y, Li X, You X. et al. Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus. Sci Transl Med. 2014;6(246):246ra99.</Citation><ArticleIdList><ArticleId IdType="pubmed">25101889</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Dong J, Mu R, Gao Y, Tan X, Li Y. et al. MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn. Arthritis Rheum. 2013;65(6):1603&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">23450709</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo S, Ding S, Liao J, Zhang P, Liu Y, Zhao M. et al. Excessive miR-152-3p Results in Increased BAFF Expression in SLE B-Cells by Inhibiting the KLF5 Expression. Front Immunol. 2019;10:1127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6538770</ArticleId><ArticleId IdType="pubmed">31178864</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin L, Fang X, Dai C, Xiang N, Tao J, Sun X. et al. The potential role of Ets-1 and miR-326 in CD19(+)B cells in the pathogenesis of patients with systemic lupus erythematosus. Clin Rheumatol. 2019;38(4):1031&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30456527</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren D, Liu F, Dong G, You M, Ji J, Huang Y. et al. Activation of TLR7 increases CCND3 expression via the downregulation of miR-15b in B cells of systemic lupus erythematosus. Cell Mol Immunol. 2016;13(6):764&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5101438</ArticleId><ArticleId IdType="pubmed">26144250</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo S, Liu Y, Liang G, Zhao M, Wu H, Liang Y. et al. The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus. Clin Epigenetics. 2015;7:24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4364674</ArticleId><ArticleId IdType="pubmed">25789080</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X, Ye L, Xu S, Guo G, Zuo Z, Ye M. et al. Downregulated miR29a promotes B cell overactivation by upregulating Crklike protein in systemic lupus erythematosus. Mol Med Rep. 2020;22(2):841&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7339478</ArticleId><ArticleId IdType="pubmed">32467986</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan VS, Nie YJ, Shen N, Yan S, Mok MY, Lau CS. Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus. Autoimmun Rev. 2012;11(12):890&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">22503660</ArticleId></ArticleIdList></Reference><Reference><Citation>Batteux F, Palmer P, Daeron M, Weill B, Lebon P. FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus. Eur Cytokine Netw. 1999;10(4):509&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">10586117</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Davidson A. IFNalpha Inducible Models of Murine SLE. Front Immunol. 2013;4:306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3788378</ArticleId><ArticleId IdType="pubmed">24106491</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Hoogen LL, Rossato M, Lopes AP, Pandit A, Bekker CPJ, Fritsch-Stork RDE. et al. microRNA downregulation in plasmacytoid dendritic cells in interferon-positive systemic lupus erythematosus and antiphospholipid syndrome. Rheumatology (Oxford) 2018;57(9):1669&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">29873766</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai R, Ahmed SA. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res. 2011;157(4):163&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3072681</ArticleId><ArticleId IdType="pubmed">21420027</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauley KM, Cha S, Chan EK. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun. 2009;32(3-4):189&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717629</ArticleId><ArticleId IdType="pubmed">19303254</ArticleId></ArticleIdList></Reference><Reference><Citation>Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, Chiu RW. et al. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem. 2008;54(3):482&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">18218722</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K. et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 2008;141(5):672&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">18318758</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2492472</ArticleId><ArticleId IdType="pubmed">18663219</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18(10):997&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pubmed">18766170</ArticleId></ArticleIdList></Reference><Reference><Citation>Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E. et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res. 2009;15(17):5473&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2752355</ArticleId><ArticleId IdType="pubmed">19706812</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanke M, Hoefig K, Merz H, Feller AC, Kausch I, Jocham D. et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol. 2010;28(6):655&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">19375957</ArticleId></ArticleIdList></Reference><Reference><Citation>Turchinovich A, Samatov TR, Tonevitsky AG, Burwinkel B. Circulating miRNAs: cell-cell communication function? Front Genet. 2013;4:119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3695387</ArticleId><ArticleId IdType="pubmed">23825476</ArticleId></ArticleIdList></Reference><Reference><Citation>Turchinovich A, Tonevitsky AG, Burwinkel B. Extracellular miRNA: A Collision of Two Paradigms. Trends Biochem Sci. 2016;41(10):883&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">27597517</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol (Lausanne) 2018;9:402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6085463</ArticleId><ArticleId IdType="pubmed">30123182</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Peng W, Ouyang X, Li W, Dai Y. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl Res. 2012;160(3):198&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">22683424</ArticleId></ArticleIdList></Reference><Reference><Citation>Motawi TK, Mohsen DA, El-Maraghy SA, Kortam MA. MicroRNA-21, microRNA-181a and microRNA-196a as potential biomarkers in adult Egyptian patients with systemic lupus erythematosus. Chem Biol Interact. 2016;260:110&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">27816459</ArticleId></ArticleIdList></Reference><Reference><Citation>Amr KS, Bayoumi FS, Elgengehy FT, Abdallah SO, Ahmed HH, Eissa E. The role of microRNA-31 and microRNA-21 as regulatory biomarkers in the activation of T lymphocytes of Egyptian lupus patients. Rheumatol Int. 2016;36(11):1617&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">27510529</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang ZM, Fang M, Wang JP, Cai PC, Wang P, Hu LH. Clinical relevance of plasma miR-21 in new-onset systemic lupus erythematosus patients. J Clin Lab Anal. 2014;28(6):446&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6807453</ArticleId><ArticleId IdType="pubmed">24659142</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC. et al. Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J Rheumatol. 2010;37(12):2516&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">20952466</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y. et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009;60(4):1065&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">19333922</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Tam LS, Kwan BC, Li EK, Chow KM, Luk CC. et al. Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus. Clin Rheumatol. 2012;31(3):435&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">21987229</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Hernandez J, Forner MJ, Pinto C, Chaves FJ, Cortes R, Redon J. Increased Urinary Exosomal MicroRNAs in Patients with Systemic Lupus Erythematosus. PLoS One. 2015;10(9):e0138618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4577109</ArticleId><ArticleId IdType="pubmed">26390437</ArticleId></ArticleIdList></Reference><Reference><Citation>Divekar AA, Dubey S, Gangalum PR, Singh RR. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu. J Immunol. 2011;186(2):924&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038632</ArticleId><ArticleId IdType="pubmed">21149603</ArticleId></ArticleIdList></Reference><Reference><Citation>Prokopi M, Pula G, Mayr U, Devue C, Gallagher J, Xiao Q. et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood. 2009;114(3):723&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">19369228</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlsen AL, Schetter AJ, Nielsen CT, Lood C, Knudsen S, Voss A. et al. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum. 2013;65(5):1324&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6662589</ArticleId><ArticleId IdType="pubmed">23401079</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie W, Li Z, Li M, Xu N, Zhang Y. miR-181a and inflammation: miRNA homeostasis response to inflammatory stimuli in vivo. Biochem Biophys Res Commun. 2013;430(2):647&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">23220232</ArticleId></ArticleIdList></Reference><Reference><Citation>Galicia JC, Naqvi AR, Ko CC, Nares S, Khan AA. MiRNA-181a regulates Toll-like receptor agonist-induced inflammatory response in human fibroblasts. Genes Immun. 2014;15(5):333&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4111836</ArticleId><ArticleId IdType="pubmed">24848932</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie W, Li M, Xu N, Lv Q, Huang N, He J. et al. MiR-181a regulates inflammation responses in monocytes and macrophages. PLoS One. 2013;8(3):e58639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3596280</ArticleId><ArticleId IdType="pubmed">23516523</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramkissoon SH, Mainwaring LA, Ogasawara Y, Keyvanfar K, McCoy JP Jr, Sloand EM. et al. Hematopoietic-specific microRNA expression in human cells. Leuk Res. 2006;30(5):643&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16226311</ArticleId></ArticleIdList></Reference><Reference><Citation>Li HS, Ning Y, Li SB, Shao PY, Chen SJ, Ye Q. et al. Expression and clinical significance of miR-181a and miR-203 in systemic lupus erythematosus patients. Eur Rev Med Pharmacol Sci. 2017;21(21):4790&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">29164585</ArticleId></ArticleIdList></Reference><Reference><Citation>Lashine YA, Seoudi AM, Salah S, Abdelaziz AI. Expression signature of microRNA-181-a reveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosus. Clin Exp Rheumatol. 2011;29(2):351&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21385555</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Huang X, Ye L, Guo G, Li X, Chen C. et al. B Cell-Related Circulating MicroRNAs With the Potential Value of Biomarkers in the Differential Diagnosis, and Distinguishment Between the Disease Activity and Lupus Nephritis for Systemic Lupus Erythematosus. Front Immunol. 2018;9:1473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6033964</ArticleId><ArticleId IdType="pubmed">30008716</ArticleId></ArticleIdList></Reference><Reference><Citation>Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103(33):12481&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1567904</ArticleId><ArticleId IdType="pubmed">16885212</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner-Svensson HM, Lindsay MA. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J Immunol. 2008;180(8):5689&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2639646</ArticleId><ArticleId IdType="pubmed">18390754</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392(10141):75&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">29937192</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S. et al. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity. 2007;27(6):847&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4135426</ArticleId><ArticleId IdType="pubmed">18055230</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303(5654):83&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">14657504</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Wu H, Zhao M, Lu Q. Identifying the differentially expressed microRNAs in autoimmunity: A systemic review and meta-analysis. Autoimmunity. 2020;53(3):122&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">31902241</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Liu L, Meng D, Wang D, Zhang J, Shi D. et al. Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Stem Cells Dev. 2012;21(13):2387&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">22375903</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong C, Zhou Q, Fu T, Zhao R, Yang J, Kong X. et al. Circulating Exosomes Derived-miR-146a from Systemic Lupus Erythematosus Patients Regulates Senescence of Mesenchymal Stem Cells. Biomed Res Int. 2019;2019:6071308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6679864</ArticleId><ArticleId IdType="pubmed">31428639</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui D, Zhu D, Ren H, Lin J, Lai W, Huang Q. et al. MicroRNA198 contributes to lupus nephritis progression by inhibition of phosphatase and tensin homology deleted on chromosome ten expression. Mol Med Rep. 2017;16(5):7813&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">28944868</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Gao J, Wang F. MiR-663a/MiR-423-5p are involved in the pathogenesis of lupus nephritis via modulating the activation of NF-kappaB by targeting TNIP2. Am J Transl Res. 2017;9(8):3796&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5575193</ArticleId><ArticleId IdType="pubmed">28861170</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Huang X, Su G, Wang L, Wu F, Zhang T. et al. High expression levels of microRNA-629, microRNA-525-5p and microRNA-516a-3p in paediatric systemic lupus erythematosus. Clin Rheumatol. 2014;33(6):807&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">24687380</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo G, Wang H, Shi X, Ye L, Wu K, Lin K. et al. NovelmiRNA-25 inhibits AMPD2 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and represents a promising novel biomarker. J Transl Med. 2018;16(1):370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6303892</ArticleId><ArticleId IdType="pubmed">30577810</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoshmirsafa M, Kianmehr N, Falak R, Mowla SJ, Seif F, Mirzaei B. et al. Elevated expression of miR-21 and miR-155 in peripheral blood mononuclear cells as potential biomarkers for lupus nephritis. Int J Rheum Dis. 2019;22(3):458&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">30398001</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen Z, Xu L, Chen X, Xu W, Yin Z, Gao X. et al. Autoantibody induction by DNA-containing immune complexes requires HMGB1 with the TLR2/microRNA-155 pathway. J Immunol. 2013;190(11):5411&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">23616573</ArticleId></ArticleIdList></Reference><Reference><Citation>Su X, Ye L, Chen X, Zhang H, Zhou Y, Ding X. et al. MiR-199-3p promotes ERK-mediated IL-10 production by targeting poly (ADP-ribose) Polymerase-1 in patients with systemic lupus erythematosus. Chem Biol Interact. 2019;306:110&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">30991045</ArticleId></ArticleIdList></Reference><Reference><Citation>Sourour SK, Aboelenein HR, Elemam NM, Abdelhamid AK, Salah S, Abdelaziz AI. Unraveling the expression of microRNA-27a* &amp; NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients. Int J Rheum Dis. 2017;20(9):1237&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">28523761</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhang C, Wu Z, Chen Y, Shi W. CircIBTK inhibits DNA demethylation and activation of AKT signaling pathway via miR-29b in peripheral blood mononuclear cells in systemic lupus erythematosus. Arthritis Res Ther. 2018;20(1):118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5993996</ArticleId><ArticleId IdType="pubmed">29884225</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Liu Y, Yuan M, Xu L, Sun H. Elevated expression of microRNA-873 facilitates Th17 differentiation by targeting forkhead box O1 (Foxo1) in the pathogenesis of systemic lupus erythematosus. Biochem Biophys Res Commun. 2017;492(3):453&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">28837808</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Tang Y, Qu B, Cui H, Wang S, Wang L. et al. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum. 2010;62(11):3425&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">20589685</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao W, Qian G, Luo W, Liu X, Pu Y, Hu G. et al. miR-125b is downregulated in systemic lupus erythematosus patients and inhibits autophagy by targeting UVRAG. Biomed Pharmacother. 2018;99:791&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">29710477</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashad DI, Abdelmagid MH, Elsherif SH. microRNA146a expression in lupus patients with and without renal complications. J Clin Lab Anal. 2012;26(1):35&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6807509</ArticleId><ArticleId IdType="pubmed">24833532</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaga H, Komatsuda A, Omokawa A, Ito M, Teshima K, Tagawa H. et al. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-alpha in PBMCs from patients with SLE. Mod Rheumatol. 2015;25(6):865&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">25775145</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen TK, Andersen T, Bak RO, Yiu G, Sorensen CM, Stengaard-Pedersen K. et al. Overexpression of microRNA-155 increases IL-21 mediated STAT3 signaling and IL-21 production in systemic lupus erythematosus. Arthritis Res Ther. 2015;17:154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4504038</ArticleId><ArticleId IdType="pubmed">26055806</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarhan RA, Aboelenein HR, Sourour SK, Fawzy IO, Salah S, Abdelaziz AI. Targeting E2F1 and c-Myc expression by microRNA-17-5p represses interferon-stimulated gene MxA in peripheral blood mononuclear cells of pediatric systemic lupus erythematosus patients. Discov Med. 2015;19(107):419&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">26175399</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Zhao H, Zhao S, Wang X. MicroRNA expression profiles of peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Acta Histochem. 2014;116(5):891&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24657071</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboelenein HR, Salah S, Lashine YA, Abdelaziz AI. Dual downregulation of microRNA 17-5p and E2F1 transcriptional factor in pediatric systemic lupus erythematosus patients. Rheumatol Int. 2013;33(5):1333&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23129428</ArticleId></ArticleIdList></Reference><Reference><Citation>Lashine YA, Salah S, Aboelenein HR, Abdelaziz AI. Correcting the expression of miRNA-155 represses PP2Ac and enhances the release of IL-2 in PBMCs of juvenile SLE patients. Lupus. 2015;24(3):240&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25253569</ArticleId></ArticleIdList></Reference><Reference><Citation>Duroux-Richard I, Cuenca J, Ponsolles C, Pineiro AB, Gonzalez F, Roubert C. et al. MicroRNA Profiling of B Cell Subsets from Systemic Lupus Erythematosus Patients Reveals Promising Novel Biomarkers. Int J Mol Sci. 2015;16(8):16953&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4581178</ArticleId><ArticleId IdType="pubmed">26225955</ArticleId></ArticleIdList></Reference><Reference><Citation>Teruel R, Perez-Sanchez C, Corral J, Herranz MT, Perez-Andreu V, Saiz E. et al. Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome. J Thromb Haemost. 2011;9(10):1985&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">21794077</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S, Fernando T, Wu PW, Seo J, Ni Gabhann J, Piskareva O. et al. MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE. J Autoimmun. 2017;79:105&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">28318807</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin F, Hu H, Xu M, Zhan S, Wang Y, Zhang H. et al. Serum microRNA Profiles Serve as Novel Biomarkers for Autoimmune Diseases. Front Immunol. 2018;9:2381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6232775</ArticleId><ArticleId IdType="pubmed">30459760</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim BS, Jung JY, Jeon JY, Kim HA, Suh CH. Circulating hsa-miR-30e-5p, hsa-miR-92a-3p, and hsa-miR-223-3p may be novel biomarkers in systemic lupus erythematosus. HLA. 2016;88(4):187&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">27596248</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng L, Wu JL, Liu LM, Jiang JQ, Wu HJ, Zhao M. et al. Serum miRNA-371b-5p and miRNA-5100 act as biomarkers for systemic lupus erythematosus. Clin Immunol. 2018;196:103&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30304699</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Sanchez C, Cecchi I, Barbarroja N, Patino-Trives AM, Luque-Tevar M, Perez-Sanchez L. et al. Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion. J Cell Mol Med. 2019;23(9):6308&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6714224</ArticleId><ArticleId IdType="pubmed">31347786</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YJ, Fan WJ, Bai JZ. microRNA-126 expression and its mechanism of action in patients with systemic lupus erythematosus. Eur Rev Med Pharmacol Sci. 2015;19(20):3838&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">26531267</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC. et al. Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus. 2011;20(5):493&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pubmed">21372198</ArticleId></ArticleIdList></Reference><Reference><Citation>Su YJ, Tsai NW, Kung CT, Wang HC, Lin WC, Huang CC. et al. Investigation of MicroRNA in Mitochondrial Apoptotic Pathway in Systemic Lupus Erythematosus. Biomed Res Int. 2018;2018:9026357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6076970</ArticleId><ArticleId IdType="pubmed">30105262</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Zhu L, Xie GL, Bao JF, Yu Q. Let-7 miRNAs Modulate the Activation of NF-kappaB by Targeting TNFAIP3 and Are Involved in the Pathogenesis of Lupus Nephritis. PLoS One. 2015;10(6):e0121256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4482407</ArticleId><ArticleId IdType="pubmed">26110642</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Wang J, Li F. Dysregulation of PTEN caused by the underexpression of microRNA130b is associated with the severity of lupus nephritis. Mol Med Rep. 2018;17(6):7966&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">29620214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM. et al. Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology (Carlton) 2012;17(4):346&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">22295894</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Hasni SA, Perez P, Tandon M, Jang SI, Zheng C. et al. miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J Am Soc Nephrol. 2013;24(7):1073&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3699828</ArticleId><ArticleId IdType="pubmed">23723424</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S, Pan W, Song X, Liu Y, Shao X, Tang Y. et al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha. Nat Med. 2012;18(7):1077&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">22660635</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasoudaki E, Banos A, Stagakis E, Loupasakis K, Drakos E, Sinatkas V. et al. Micro-RNA analysis of renal biopsies in human lupus nephritis demonstrates up-regulated miR-422a driving reduction of kallikrein-related peptidase 4. Nephrol Dial Transplant. 2016;31(10):1676&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">26546590</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Wang Y, Zhang X, Qin Y, Qu B, Wu L. et al. MicroRNA-130b Ameliorates Murine Lupus Nephritis Through Targeting the Type I Interferon Pathway on Renal Mesangial Cells. Arthritis Rheumatol. 2016;68(9):2232&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">27111096</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng CZ, Shu YB, Luo YL, Luo J. The role of miR-146a in modulating TRAF6-induced inflammation during lupus nephritis. Eur Rev Med Pharmacol Sci. 2017;21(5):1041&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">28338190</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa-Reis P, Russo PA, Zhang Z, Colonna L, Maurer K, Gallucci S. et al. The Role of MicroRNAs and Human Epidermal Growth Factor Receptor 2 in Proliferative Lupus Nephritis. Arthritis Rheumatol. 2015;67(9):2415&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7814461</ArticleId><ArticleId IdType="pubmed">26016809</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao F, Sun L, Fang W, Wang H, Yao D, Cui R. et al. HsamiR3715p inhibits human mesangial cell proliferation and promotes apoptosis in lupus nephritis by directly targeting hypoxiainducible factor 1alpha. Mol Med Rep. 2016;14(6):5693&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">27878241</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Xue Z, Di L. Regulation of MiR-146a and TRAF6 in the Diagnose of Lupus Nephritis. Med Sci Monit. 2017;23:2550&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5455804</ArticleId><ArticleId IdType="pubmed">28549054</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafari Ghods F, Topal Sarikaya A, Arda N, Hamuryudan V. MiRNA and mRNA Profiling in Systemic Lupus Reveals a Novel Set of Cytokine - Related miRNAs and their Target Genes in Cases With and Without Renal Involvement. Kidney Blood Press Res. 2017;42(6):1322&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">29258102</ArticleId></ArticleIdList></Reference><Reference><Citation>Zununi Vahed S, Nakhjavani M, Etemadi J, Jamshidi H, Jadidian N, Pourlak T. et al. Altered levels of immune-regulatory microRNAs in plasma samples of patients with lupus nephritis. Bioimpacts. 2018;8(3):177&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6128973</ArticleId><ArticleId IdType="pubmed">30211077</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardenas-Gonzalez M, Srivastava A, Pavkovic M, Bijol V, Rennke HG, Stillman IE. et al. Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy. Clin Chem. 2017;63(9):1515&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5610914</ArticleId><ArticleId IdType="pubmed">28667184</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Mou S, Wang L, Zhang M, Shao X, Fang W. et al. Up-regulation of Serum MiR-130b-3p Level is Associated with Renal Damage in Early Lupus Nephritis. Sci Rep. 2015;5:12644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4551961</ArticleId><ArticleId IdType="pubmed">26316103</ArticleId></ArticleIdList></Reference><Reference><Citation>Qingjuan L, Xiaojuan F, Wei Z, Chao W, Pengpeng K, Hongbo L. et al. miR-148a-3p overexpression contributes to glomerular cell proliferation by targeting PTEN in lupus nephritis. Am J Physiol Cell Physiol. 2016;310(6):C470&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26791485</ArticleId></ArticleIdList></Reference><Reference><Citation>Sole C, Moline T, Vidal M, Ordi-Ros J, Cortes-Hernandez J. An Exosomal Urinary miRNA Signature for Early Diagnosis of Renal Fibrosis in Lupus Nephritis. Cells. 2019. 8(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6721515</ArticleId><ArticleId IdType="pubmed">31349698</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakhjavani M, Etemadi J, Pourlak T, Mirhosaini Z, Zununi Vahed S, Abediazar S. Plasma levels of miR-21, miR-150, miR-423 in patients with lupus nephritis. Iran J Kidney Dis. 2019;13(3):198&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">31209193</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Wang G, Zhang X, Dou Y, Dong Y, Liu D. et al. Inhibition of microRNA-182-5p contributes to attenuation of lupus nephritis via Foxo1 signaling. Exp Cell Res. 2018;373(1-2):91&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30308195</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Xu X, Tang X, Bian X, Shen B, Zhao H. et al. MicroRNA expression profile of urinary exosomes in Type IV lupus nephritis complicated by cellular crescent. J Biol Res (Thessalon) 2018;25:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6172751</ArticleId><ArticleId IdType="pubmed">30306067</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangtanatakul P, Klinchanhom S, Sodsai P, Sutichet T, Promjeen C, Avihingsanon Y. et al. Down-regulation of let-7a and miR-21 in urine exosomes from lupus nephritis patients during disease flare. Asian Pac J Allergy Immunol. 2019;37(4):189&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">30118248</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Wang Y. The correlation of plasma microRNA-200 family expressions with risk and disease severity of lupus nephritis. Eur Rev Med Pharmacol Sci. 2018;22(10):3118&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">29863256</ArticleId></ArticleIdList></Reference><Reference><Citation>Sole C, Cortes-Hernandez J, Felip ML, Vidal M, Ordi-Ros J. miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. Nephrol Dial Transplant. 2015;30(9):1488&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">26040904</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro-Quiroz E, Pacheco-Lugo L, Navarro-Quiroz R, Lorenzi H, Espana-Puccini P, Diaz-Olmos Y. et al. Profiling analysis of circulating microRNA in peripheral blood of patients with class IV lupus nephritis. PLoS One. 2017;12(11):e0187973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5685598</ArticleId><ArticleId IdType="pubmed">29136041</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>